Literature DB >> 30882477

High-Flow Oxygen Therapy After Noninvasive Ventilation Interruption in Patients Recovering From Hypercapnic Acute Respiratory Failure: A Physiological Crossover Trial.

Federico Longhini1, Lara Pisani2, Ramona Lungu3, Vittoria Comellini2, Andrea Bruni4, Eugenio Garofalo4, Maria Laura Vega2, Gianmaria Cammarota3, Stefano Nava2, Paolo Navalesi4.   

Abstract

OBJECTIVES: Assessing gas exchange, diaphragm function, respiratory rate, and patient comfort during high-flow oxygen therapy and standard oxygen at the time of noninvasive ventilation discontinuation.
DESIGN: Randomized crossover physiologic study.
SETTING: Two ICUs. PATIENTS: Thirty chronic obstructive pulmonary disease patients with hypercapnic acute respiratory failure receiving noninvasive ventilation greater than 24 hours.
INTERVENTIONS: All patients underwent five 30-minute trials, the first, third, and fifth trial in noninvasive ventilation, whereas the second and fourth were randomly conducted with either standard oxygen and high-flow oxygen therapy.
MEASUREMENTS AND MAIN RESULTS: Diaphragm displacement and thickening fraction were determined by sonographic evaluation at the end of each trial. Arterial blood gases, respiratory rate, and patient comfort were also assessed. PaCO2 (p = 0.153) and pH (p = 0.114) were not different among trials, while PaO2 was greater in noninvasive ventilation than with both standard oxygen (p ≤ 0.005) and high-flow oxygen therapy (p ≤ 0.001). The diaphragm displacement was no different among trials (p = 0.875), while its thickening fraction was greater with standard oxygen, compared with high-flow oxygen therapy and all noninvasive ventilation trials (p < 0.001 for all comparisons), without differences between high-flow oxygen therapy and noninvasive ventilation. Respiratory rate also increased with standard oxygen, compared with both high-flow oxygen therapy (p < 0.001) and noninvasive ventilation (p < 0.01). High-flow oxygen therapy improved comfort, compared with standard oxygen (p = 0.004) and noninvasive ventilation (p < 0.001).
CONCLUSIONS: At the time of noninvasive ventilation interruption, PaCO2 and diaphragm displacement remained unchanged regardless of the modality of oxygen administration. However, although standard oxygen resulted in a remarkable increase in diaphragm thickening fraction, high-flow oxygen therapy allowed maintaining it unchanged, while improving patient comfort.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30882477     DOI: 10.1097/CCM.0000000000003740

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  19 in total

Review 1.  Clinical Evidence of Nasal High-Flow Therapy in Chronic Obstructive Pulmonary Disease Patients.

Authors:  Judith Elshof; Marieke L Duiverman
Journal:  Respiration       Date:  2020-01-28       Impact factor: 3.580

Review 2.  High-flow nasal cannulae for respiratory support in adult intensive care patients.

Authors:  Amanda Corley; Claire M Rickard; Leanne M Aitken; Amy Johnston; Adrian Barnett; John F Fraser; Sharon R Lewis; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2017-05-30

3.  Recommendations from the Italian intersociety consensus on Perioperative Anesthesa Care in Thoracic surgery (PACTS) part 2: intraoperative and postoperative care.

Authors:  Federico Piccioni; Andrea Droghetti; Alessandro Bertani; Cecilia Coccia; Antonio Corcione; Angelo Guido Corsico; Roberto Crisci; Carlo Curcio; Carlo Del Naja; Paolo Feltracco; Diego Fontana; Alessandro Gonfiotti; Camillo Lopez; Domenico Massullo; Mario Nosotti; Riccardo Ragazzi; Marco Rispoli; Stefano Romagnoli; Raffaele Scala; Luigia Scudeller; Marco Taurchini; Silvia Tognella; Marzia Umari; Franco Valenza; Flavia Petrini
Journal:  Perioper Med (Lond)       Date:  2020-10-23

4.  High-flow nasal cannulae for respiratory support in adult intensive care patients.

Authors:  Sharon R Lewis; Philip E Baker; Roses Parker; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-03-04

5.  Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis.

Authors:  Andrea Bruni; Eugenio Garofalo; Valeria Zuccalà; Giuseppe Currò; Carlo Torti; Giuseppe Navarra; Giovambattista De Sarro; Paolo Navalesi; Federico Longhini; Michele Ammendola
Journal:  World J Emerg Surg       Date:  2020-07-02       Impact factor: 5.469

6.  Comparisons of two diaphragm ultrasound-teaching programs: a multicenter randomized controlled educational study.

Authors:  Eugenio Garofalo; Andrea Bruni; Corrado Pelaia; Giovanni Landoni; Alberto Zangrillo; Massimo Antonelli; Giorgio Conti; Daniele Guerino Biasucci; Giovanna Mercurio; Andrea Cortegiani; Antonino Giarratano; Luigi Vetrugno; Tiziana Bove; Francesco Forfori; Francesco Corradi; Rosanna Vaschetto; Gianmaria Cammarota; Marinella Astuto; Paolo Murabito; Valentina Bellini; Massimo Zambon; Federico Longhini; Paolo Navalesi; Elena Bignami
Journal:  Ultrasound J       Date:  2019-10-03

Review 7.  How to ventilate obstructive and asthmatic patients.

Authors:  Alexandre Demoule; Laurent Brochard; Martin Dres; Leo Heunks; Amal Jubran; Franco Laghi; Armand Mekontso-Dessap; Stefano Nava; Lamia Ouanes-Besbes; Oscar Peñuelas; Lise Piquilloud; Theodoros Vassilakopoulos; Jordi Mancebo
Journal:  Intensive Care Med       Date:  2020-11-09       Impact factor: 17.440

8.  High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial.

Authors:  Dingyu Tan; Joseph Harold Walline; Bingyu Ling; Yan Xu; Jiayan Sun; Bingxia Wang; Xueqin Shan; Yunyun Wang; Peng Cao; Qingcheng Zhu; Ping Geng; Jun Xu
Journal:  Crit Care       Date:  2020-08-06       Impact factor: 9.097

Review 9.  High-flow nasal cannula oxygen therapy as an emerging option for respiratory failure: the present and the future.

Authors:  Lucia Spicuzza; Matteo Schisano
Journal:  Ther Adv Chronic Dis       Date:  2020-05-13       Impact factor: 5.091

10.  Severe myocarditis due to influenza A(H1N1)pdm09 viral infection in a young woman successfully treated with intravenous zanamivir: A case report.

Authors:  Maria Mazzitelli; Eugenio Garofalo; Andrea Bruni; Giorgio Settimo Barreca; Angela Quirino; Aida Giancotti; Francesca Serapide; Ciro Indolfi; Giovanni Matera; Paolo Navalesi; Enrico Maria Trecarichi; Carlo Torti; Federico Longhini
Journal:  Clin Case Rep       Date:  2019-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.